May 21, 2019

Ganja liqui-gel medication closer to production

The medical sciences research company, MMJ International Holdings, based in the United States and Jamaica, has reached an agreement with Thermo Fisher Scientific to manufacture its […]
May 14, 2019

MMJ International Holdings Following FDA Guidance in Cannabis Drug Development Process

ST. PETERSBURG, FL / ACCESSWIRE / May 10, 2019 / MMJ International Holdings, the premier medical cannabis research company, recently announced that the FDA has made […]
May 3, 2019

Hall Of Flowers: Acquisitions And Celebrity Cannabis Debuts

Curaleaf is Acquiring Select Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”), a vertically integrated cannabis operator in the United States, announced today it has signed […]
February 28, 2019

Ed Begley’s Jr TV Innovation Series Interviews MMJ International Holdings Marijuana Science Team

Ed Begley’s Jr TV Innovation Series Interviews MMJ International Holdings Marijuana Science Team Creating Awareness About the Science of Medical Marijuana MMJ is all about helping […]
November 14, 2018

MMJ International Holdings Files FDA Orphan Drug Application for Huntington’s Disease

MMJ International Holdings, the premier medical cannabis research company, announced that is has filed an application with the FDA for “Orphan Drug Designation” for its drug […]
August 3, 2018

MMJ International Holdings Files FDA Application for Huntington’s Disease for Pharmaceutical Cannabis Medicine Study Approval

RESTON, VA / ACCESSWIRE / August 3, 2018 / MMJ International Holdings, the premier medical sciences research company that is currently advancing the science of medical […]
February 5, 2018

MMJ International Holdings Responds to Jeff Sessions Ruling

RESTON, VA / ACCESSWIRE / February 5, 2018 / MMJ International Holdings, the premier medical cannabis research company that is advancing the science of medical marijuana […]
January 13, 2018

MMJ BioScience Files Pre Investigational New Drug (IND) Application With FDA For Pharmaceutical Cannabidiol (CBD) derived medicine.

MMJ BioScience’s FDA application to initiate clinical trials assessing the company’s cannabinoid pharmaceutical compounds for treating and/or preventing symptoms associated with multiple sclerosis (MS) has been […]
January 8, 2018

MMJ International Holdings Files US Patent Prior to FDA Study for Cannabinoid Treatment Medicine

MMJ International Holdings Files US Patent Prior to FDA Study for Cannabinoid Treatment Medicine RESTON, VA / ACCESSWIRE / January 2, 2018 / MMJ International Holdings, […]